Atreca Inc (NASDAQ:BCEL)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - BCEL
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - BCEL
- Market Cap$568.950m
- SymbolNASDAQ:BCEL
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS04965G1094
Company Profile
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Latest BCEL news
Currently there for this company. Visit our news hub for other news .